- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gene Therapies for Cancer Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gene Therapies for Cancer Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapies for Cancer Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Type 1
Type 2
Type 3
By End-User:
Application 1
Application 2
Application 3
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapies for Cancer Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 1 from 2016 to 2027
-
1.3.2 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 2 from 2016 to 2027
-
1.3.3 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 3 from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 1 from 2016 to 2027
-
1.4.2 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 2 from 2016 to 2027
-
1.4.3 USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 3 from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gene Therapies for Cancer Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapies for Cancer Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Type 1
-
3.4.2 Market Size and Growth Rate of Type 2
-
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Gene Therapies for Cancer Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapies for Cancer Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene Therapies for Cancer Treatment in Application 1
-
4.4.2 Market Size and Growth Rate of Gene Therapies for Cancer Treatment in Application 2
-
4.4.3 Market Size and Growth Rate of Gene Therapies for Cancer Treatment in Application 3
5 Market Analysis by Regions
-
5.1 USA Gene Therapies for Cancer Treatment Production Analysis by Regions
-
5.2 USA Gene Therapies for Cancer Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gene Therapies for Cancer Treatment Landscape Analysis
-
6.1 West USA Gene Therapies for Cancer Treatment Landscape Analysis by Major Types
-
6.2 West USA Gene Therapies for Cancer Treatment Landscape Analysis by Major End-Users
7 South USA Gene Therapies for Cancer Treatment Landscape Analysis
-
7.1 South USA Gene Therapies for Cancer Treatment Landscape Analysis by Major Types
-
7.2 South USA Gene Therapies for Cancer Treatment Landscape Analysis by Major End-Users
8 Middle West USA Gene Therapies for Cancer Treatment Landscape Analysis
-
8.1 Middle West USA Gene Therapies for Cancer Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Gene Therapies for Cancer Treatment Landscape Analysis by Major End-Users
9 Northeast USA Gene Therapies for Cancer Treatment Landscape Analysis
-
9.1 Northeast USA Gene Therapies for Cancer Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Gene Therapies for Cancer Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Company 1
-
10.1.1 Company 1 Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Company 2
-
10.2.1 Company 2 Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Company 3
-
10.3.1 Company 3 Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Company 4
-
10.4.1 Company 4 Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Company 5
-
10.5.1 Company 5 Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Company 6
-
10.6.1 Company 6 Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Company 7
-
10.7.1 Company 7 Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Company 8
-
10.8.1 Company 8 Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Company 9
-
10.9.1 Company 9 Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Company 10
-
10.10.1 Company 10 Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 1 from 2016 to 2027
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 2 from 2016 to 2027
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Type 3 from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 1 from 2016 to 2027
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 2 from 2016 to 2027
-
Figure USA Gene Therapies for Cancer Treatment Market Size and Growth Rate of Application 3 from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gene Therapies for Cancer Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gene Therapies for Cancer Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapies for Cancer Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Gene Therapies for Cancer Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Type 1
-
Figure Market Size and Growth Rate of Type 2
-
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gene Therapies for Cancer Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gene Therapies for Cancer Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Application 1
-
Figure Market Size and Growth Rate of Application 2
-
Figure Market Size and Growth Rate of Application 3
-
Table USA Gene Therapies for Cancer Treatment Production by Regions
-
Table USA Gene Therapies for Cancer Treatment Production Share by Regions
-
Figure USA Gene Therapies for Cancer Treatment Production Share by Regions in 2016
-
Figure USA Gene Therapies for Cancer Treatment Production Share by Regions in 2021
-
Figure USA Gene Therapies for Cancer Treatment Production Share by Regions in 2027
-
Table USA Gene Therapies for Cancer Treatment Consumption by Regions
-
Table USA Gene Therapies for Cancer Treatment Consumption Share by Regions
-
Figure USA Gene Therapies for Cancer Treatment Consumption Share by Regions in 2016
-
Figure USA Gene Therapies for Cancer Treatment Consumption Share by Regions in 2021
-
Figure USA Gene Therapies for Cancer Treatment Consumption Share by Regions in 2027
-
Table West USA Gene Therapies for Cancer Treatment Consumption by Types from 2016 to 2027
-
Table West USA Gene Therapies for Cancer Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2016
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2021
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2027
-
Table West USA Gene Therapies for Cancer Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2016
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2021
-
Figure West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2027
-
Table South USA Gene Therapies for Cancer Treatment Consumption by Types from 2016 to 2027
-
Table South USA Gene Therapies for Cancer Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2016
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2021
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2027
-
Table South USA Gene Therapies for Cancer Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Gene Therapies for Cancer Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2016
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2021
-
Figure South USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Gene Therapies for Cancer Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Gene Therapies for Cancer Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2027
-
Table Middle West USA Gene Therapies for Cancer Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Gene Therapies for Cancer Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Gene Therapies for Cancer Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by Types in 2027
-
Table Northeast USA Gene Therapies for Cancer Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gene Therapies for Cancer Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Gene Therapies for Cancer Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Company 1
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 1
-
Figure Sales and Growth Rate Analysis of Company 1
-
Figure Revenue and Market Share Analysis of Company 1
-
Table Product and Service Introduction of Company 1
-
Table Company Profile and Development Status of Company 2
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 2
-
Figure Sales and Growth Rate Analysis of Company 2
-
Figure Revenue and Market Share Analysis of Company 2
-
Table Product and Service Introduction of Company 2
-
Table Company Profile and Development Status of Company 3
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 3
-
Figure Sales and Growth Rate Analysis of Company 3
-
Figure Revenue and Market Share Analysis of Company 3
-
Table Product and Service Introduction of Company 3
-
Table Company Profile and Development Status of Company 4
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 4
-
Figure Sales and Growth Rate Analysis of Company 4
-
Figure Revenue and Market Share Analysis of Company 4
-
Table Product and Service Introduction of Company 4
-
Table Company Profile and Development Status of Company 5
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 5
-
Figure Sales and Growth Rate Analysis of Company 5
-
Figure Revenue and Market Share Analysis of Company 5
-
Table Product and Service Introduction of Company 5
-
Table Company Profile and Development Status of Company 6
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 6
-
Figure Sales and Growth Rate Analysis of Company 6
-
Figure Revenue and Market Share Analysis of Company 6
-
Table Product and Service Introduction of Company 6
-
Table Company Profile and Development Status of Company 7
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 7
-
Figure Sales and Growth Rate Analysis of Company 7
-
Figure Revenue and Market Share Analysis of Company 7
-
Table Product and Service Introduction of Company 7
-
Table Company Profile and Development Status of Company 8
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 8
-
Figure Sales and Growth Rate Analysis of Company 8
-
Figure Revenue and Market Share Analysis of Company 8
-
Table Product and Service Introduction of Company 8
-
Table Company Profile and Development Status of Company 9
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 9
-
Figure Sales and Growth Rate Analysis of Company 9
-
Figure Revenue and Market Share Analysis of Company 9
-
Table Product and Service Introduction of Company 9
-
Table Company Profile and Development Status of Company 10
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 10
-
Figure Sales and Growth Rate Analysis of Company 10
-
Figure Revenue and Market Share Analysis of Company 10
-
Table Product and Service Introduction of Company 10
-